Evolent Health, Inc. - Class A Shares (EVH) Technical Analysis
$8.78▲1.86%
Market is closed - opens 7 PM, 21 May 2025
Insights
- Evolent Health - Class A Shares is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Evolent Health - Class A Shares stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Evolent Health - Class A Shares stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Evolent Health - Class A Shares stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 41.09 | Neutral |
Stochastic | 8.26, 7.05 | Buy |
Ultimate Oscillator | 44.31 | Neutral |
Stochastic Relative Strength Index | 3.28, 1.22 | Buy |
Moving Average Convergence Divergence | -0.21, -0.07 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.29 | Sell |
20 | 9.52 | Sell |
50 | 9.57 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.13 | Sell |
20 | 9.35 | Sell |
50 | 9.57 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.42 | Sell |
20 | 9.53 | Sell |
50 | 9.56 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 8.78 | Sell |
20 | 9.13 | Sell |
50 | 9.24 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 8.57 | Sell |
20 | 8.93 | Sell |
50 | 9.28 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 8.94 |
Resistance L2 | 8.85 |
Resistance L1 | 8.74 |
Pivot Point | 8.65 |
Support L1 | 8.54 |
Support L2 | 8.45 |
Support L3 | 8.34 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.